Product
Pertzye
1 clinical trial
7 indications
Indication
Pancreatic Ductal AdenocarcinomaIndication
Pancreatic CancerIndication
Pancreatic CarcinomaIndication
Pancreatic Carcinoma MetastaticIndication
Pancreatic Carcinoma Non-resectableIndication
Pancreatic Cancer MetastaticIndication
PDACClinical trial
A Randomized Double Blind Study of Pancreatic Enzyme Replacement Therapy for Patients With Metastatic Pancreatic Ductal AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-11-30